ARTICLE | Tools & Techniques
Broad takes RNA CRISPR into viral infections
Cas13 continues to prove its worth as the latest Broad CRISPR study points to antiviral applications
October 10, 2019 11:23 PM UTC
The latest CRISPR study from the Broad Institute takes gene editing into infections caused by RNA viruses, using Cas13 -- which is proving to be one of the most versatile of the CRISPR-Cas enzyme family.
In a paper published in Molecular Cell on Thursday, a Broad Institute of MIT and Harvard team led by Pardis Sabeti showed that CRISPR-Cas13 can kill RNA viruses in infected cells...
BCIQ Company Profiles